However, patients with NAFLD had a higher DBP, a serum level of total cholesterol, uric acid, AST, and ALT, and also, their BMI was higher than that of patients without NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.